Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective

Biliary tract cancer (BTC) is a group of rare and aggressive malignancies with a dismal prognosis. There is currently a significant lack in effective treatment options for BTC, with gemcitabine-cisplatin remaining the first-line standard of care treatment for over a decade. A wave of investigational...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Vincent C. Tam, Ravi Ramjeesingh, Ronald Burkes, Eric M. Yoshida, Sarah Doucette, Howard J. Lim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-09-01
coleção:	Current Oncology
Assuntos:	biliary tract cancer rare disease chemotherapy immunotherapy targeted therapy drug access
Acesso em linha:	https://www.mdpi.com/1718-7729/29/10/555
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!